Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia.

about

Prevalence of polymorphisms in the ANKK1, DRD2, DRD3 genes and metabolic syndrome in refractory schizophrenia.

Item

http://www.wikidata.org/entity/Q55003248

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Prevalence of polymorphisms in ...... e in refractory schizophrenia.

@en

Prevalence of polymorphisms in ...... e in refractory schizophrenia.

@nl

type

Item

label

Prevalence of polymorphisms in ...... e in refractory schizophrenia.

@en

Prevalence of polymorphisms in ...... e in refractory schizophrenia.

@nl

prefLabel

Prevalence of polymorphisms in ...... e in refractory schizophrenia.

@en

Prevalence of polymorphisms in ...... e in refractory schizophrenia.

@nl

P1476

Prevalence of polymorphisms in ...... me in refractory schizophrenia

@en

P2093

Jeizziani Aparecida Ferreira Pinto

http://www.w3.org/2001/XMLSchema#string

Paulo Afonso Granjeiro

http://www.w3.org/2001/XMLSchema#string

Pedro Henrique Batista de Freitas

http://www.w3.org/2001/XMLSchema#string

Richardson Miranda Machado

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation

Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study.

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia.

Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia.

Genetic Effects on Longitudinal Changes from Healthy to Adverse Weight and Metabolic Status – The HUNT Study.

Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.

The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review.

A family affair: brain abnormalities in siblings of patients with schizophrenia.

P304

e2983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1518-8345.2222.2983

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabio Daumas Nunes

Luciana L Santos

P577

2018-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29791666

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

metabolic syndrome

P932

5969827

http://www.w3.org/2001/XMLSchema#string